Erik D. Roberson MD PhD
Neurodegenerative, Dementia & Geriatrics
Rebecca Gale-Heersink Endowed Chair; Director, Alzheimer's Disease Center; Director, Center for Neurodegeneration and Experimental Therapeutics
Join to View Full Profile
1717 6th Ave SBirmingham, AL 35233
Phone+1 800-822-8816
Fax+1 205-975-7365
Dr. Roberson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Residency, Neurology, 2000 - 2003
Baylor College of MedicineInternship, Transitional Year, 1999 - 2000- Baylor College of MedicineClass of 1999
Certifications & Licensure
CA State Medical License 2001 - Present
AL State Medical License 2008 - 2025
American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001
- Safety Study of TPI-287 to Treat CBS and PSP Start of enrollment: 2014 May 01
Publications & Presentations
PubMed
- Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, ...Randall J Bateman, Yan Li, Eric M McDade, Jorge J Llibre-Guerra, David B Clifford
The Lancet. Neurology. 2025-04-01 - Comprehensive cross-sectional and longitudinal comparisons of plasma glial fibrillary acidic protein and neurofilament light across FTD spectrum disorders.Udit Sheth, Linn Öijerstedt, Michael G Heckman, Launia J White, Hilary W Heuer
Molecular Neurodegeneration. 2025-03-12 - Psychotropic medication usage in sporadic versus genetic behavioral-variant frontotemporal dementia.Juan-Camilo Vargas-Gonzalez, Nico Dimal, Kasey Cortez, Hilary Heuer, Leah K Forsberg
Alzheimer's & Dementia. 2025-02-01
Journal Articles
- Reduction of Microglial Progranulin Does Not Exacerbate Pathology or Behavioral Deficits in Neuronal Progranulin-Insufficient MiceErik Roberson, MD, ScienceDirect
Press Mentions
Heersink Office of Research Emphasizes Collaboration and Innovation at 2025 Annual Research RetreatMarch 4th, 2025- Gift Advances Alzheimer’s Disease ResearchJanuary 17th, 2023
- $5 Million Gift to UAB Will Support Alzheimer’s Disease ResearchOctober 31st, 2022
- Join now to see all
Grant Support
- UAB Alzheimer's Disease Research CenterUNIVERSITY OF ALABAMA AT BIRMINGHAM2024–2029
- UAB Training Program in NeurodegenerationUNIVERSITY OF ALABAMA AT BIRMINGHAM2017–2027
- UAB Training Program in NeurodegenerationUNIVERSITY OF ALABAMA AT BIRMINGHAM2017–2027
- UAB Training Program in NeurodegenerationUNIVERSITY OF ALABAMA AT BIRMINGHAM2017–2027
- Circadian changes in network excitability and Alzheimer disease pathogenesisUNIVERSITY OF ALABAMA AT BIRMINGHAM2021–2026
- Circadian changes in network excitability and Alzheimer disease pathogenesisUNIVERSITY OF ALABAMA AT BIRMINGHAM2021–2026
- Circadian changes in network excitability and Alzheimer disease pathogenesisUNIVERSITY OF ALABAMA AT BIRMINGHAM2021–2026
- Circadian changes in network excitability and Alzheimer disease pathogenesisUNIVERSITY OF ALABAMA AT BIRMINGHAM2021–2026
- Circadian changes in network excitability and Alzheimer disease pathogenesisUNIVERSITY OF ALABAMA AT BIRMINGHAM2021–2026
- Circadian changes in network excitability and Alzheimer disease pathogenesisUNIVERSITY OF ALABAMA AT BIRMINGHAM2021–2026
- Mechanisms For The Benefit Of TAU Reduction In Alzheimer Disease ModelsNational Institute Of Neurological Disorders And Stroke2011–2012
- Mechanisms For TAU Involvement In Alzheimer'S DiseaseNational Institute Of Neurological Disorders And Stroke2008–2010
- Mechanisms For TAU Involvement In Alzheimer'S DiseaseNational Institute Of Neurological Disorders And Stroke2006–2008
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
